Targeting STAT5B in T-cell acute lymphoblastic leukemia

被引：0
|
作者：
Veloso, Alexandra [1 ,2 ]
Cools, Jan [1 ,2 ]
机构：
[1] Katholieke Univ Leuven, Leuven, Belgium
[2] VIB, Leuven, Belgium
来源：
BLOOD | 2023年 / 142卷 / 03期
关键词：
INHIBITION;
D O I：
10.1182/blood.2023020639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Tremblay et al demonstrate that STAT5B activation drives proliferation, self-renewal, and chemoresistance of leukemia stem cells (LSCs) in an early T-cell precursor acute lymphoblastic leukemia mouse model and explore STAT5B as a direct therapeutic target (see figure).(1)
引用
收藏
页码：215 / 217
页数：3
相关论文
共 50 条
  • [31] AKR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA - MODEL FOR HUMAN T-CELL LEUKEMIA
    BORTIN, MM
    TRUITT, RL
    BIOMEDICINE, 1977, 26 (05): : 309 - 311
  • [32] T-Cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia
    Mantadakis, Elpis
    Danilatou, Vassiliki
    Stiakaki, Eftichia
    Paterakis, George
    Papadhimitriou, Stefanos
    Kalmanti, Maria
    PEDIATRIC BLOOD & CANCER, 2007, 48 (03) : 354 - 357
  • [33] T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma: One disease or two?
    Raetz, EA
    Perkins, SL
    Bhojwani, D
    Carroll, WL
    Min, DJ
    BLOOD, 2003, 102 (11) : 578A - 578A
  • [34] Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia
    Bontoux, Christophe
    Simonin, Mathieu
    Garnier, Nathalie
    Lhermitte, Ludovic
    Touzart, Aurore
    Andrieu, Guillaume
    Bruneau, Julie
    Lengline, Etienne
    Plesa, Adriana
    Boissel, Nicolas
    Baruchel, Andre
    Bertrand, Yves
    Molina, Thierry Jo
    Macintyre, Elizabeth
    Asnafi, Vahid
    MODERN PATHOLOGY, 2022, 35 (09) : 1227 - 1235
  • [35] Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue
    Kagami, S
    Nakajima, H
    Kumano, K
    Suzuki, K
    Suto, A
    Imada, K
    Davey, HW
    Saito, Y
    Takatsu, K
    Leonard, WJ
    Iwamoto, I
    BLOOD, 2000, 95 (04) : 1370 - 1377
  • [36] Development of Proteolytic Targeting Chimeras to Target Lck in T-Cell Acute Lymphoblastic Leukemia
    Hu, Jianzhong
    Jarusiewicz, Jamie
    Min, Jaeki
    Yang, Lei
    Chepyala, Divyabharathi
    Actis, Marisa
    Rowland, Lauren
    Du, Guoqing
    Smart, Brandon
    Maxwell, Dylan
    Xie, Boer
    Yoshimura, Satoshi
    Peng, Junmin
    Teachey, David
    Rankovic, Zoran
    Yang, Jun J.
    BLOOD, 2021, 138
  • [37] Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset
    Padi, Sathish Kumar Reddy
    Luevano, Libia
    Singh, Neha
    Song, Jiin
    Pandey, Ritu
    Aster, Jon C.
    Yu, Xue-Zhong
    Mehrotra, Shikhar
    Kraft, Andrew
    CANCER RESEARCH, 2017, 77
  • [38] Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
    Yana Pikman
    Nicole Ocasio-Martinez
    Gabriela Alexe
    Boris Dimitrov
    Samuel Kitara
    Frances F. Diehl
    Amanda L. Robichaud
    Amy Saur Conway
    Linda Ross
    Angela Su
    Frank Ling
    Jun Qi
    Giovanni Roti
    Caroline A. Lewis
    Alexandre Puissant
    Matthew G. Vander Heiden
    Kimberly Stegmaier
    Leukemia, 2022, 36 : 348 - 360
  • [39] Therapeutic Targeting of NOTCH1 Signaling in T-Cell Acute Lymphoblastic Leukemia
    Palomero, Teresa
    Ferrando, Adolfo
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S205 - S210
  • [40] Therapeutic Targeting of PIM Protein Kinases in a Subset of T-Cell Acute Lymphoblastic Leukemia
    Padi, Sathish Kumar Reddy
    Luevano, Libia A.
    An, Ningfei
    Pandey, Ritu
    Singh, Neha
    Song, Jin H.
    Aster, Jon C.
    Yu, Xue-Zhong
    Mehrotra, Shikhar
    Kraft, Andrew S.
    BLOOD, 2016, 128 (22)
12345